Search

Your search keyword '"P. Graff-Cailleaud"' showing total 38 results

Search Constraints

Start Over You searched for: Author "P. Graff-Cailleaud" Remove constraint Author: "P. Graff-Cailleaud"
38 results on '"P. Graff-Cailleaud"'

Search Results

2. Brachytherapy boost (BT-boost) or stereotactic body radiation therapy boost (SBRT-boost) for high-risk prostate cancer (HR-PCa)

Catalog

Books, media, physical & digital resources

3. [Challenges and limits of therapeutic de-escalation for papillomavirus-related oropharyngeal cancer]

4. Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis

5. Traitement du cancer de la prostate localisé à l’apex par curiethérapie ou ultrasons focalisés

6. [Concurrent chemoradiotherapy for head neck cancers. Should organs at risk dose constraints be revisited ?]

7. Curiethérapie de la prostate : évolutions des indications et des techniques

8. Validation interne au GORTEC du consensus international de délinéation des CTV-P pour les cancers des VADS (méthode de consensus formalisé) : résultats des phases de cotation

9. [Indications and outlooks of radiohormonal therapy of high-risk prostate cancers]

10. Managing Discordant Findings Between Multiparametric Magnetic Resonance Imaging and Transrectal Magnetic Resonance Imaging–directed Prostate Biopsy—The Key Role of Magnetic Resonance Imaging–directed Transperineal Biopsy

11. [Prostate brachytherapy: New techniques, new indications]

12. Traitement du cancer de la prostate localisé à l'apex par curiethérapie ou ultrasons focalisés.

13. PO-0812: Dosimetric impact of using Acuros algorithm for stereotactic lung and spine treatments

14. P13. Spine SBRT: Benefit of Magnetic Resonance Imaging acquisition in treatment position and first results of Volumetric Modulated Arc Therapy dose plan

15. Traitement médical ou chirurgical des cancers de l’oropharynx : place du statut p16 dans la décision thérapeutique ?

16. Setting up for prostate focal brachytherapy at the Institut Universitaire du Cancer of Toulouse: Aspects of multi-modal registration and dosimetric feasibility

18. Dosimetric comparison between conformal radiation therapy and intensity modulated radiation therapy for high-dose prostate radiation. A paradoxical increased dose to the anterior rectal wall

19. Classification des discordances radio-anatomopathologiques des biopsies transrectales guidées par l’IRM

20. GETUG-AFU 17 : étude de phase III randomisée comparant la radiothérapie adjuvante à la radiothérapie de rattrapage précoce, combinées à l’hormonothérapie courte, pour les patients présentant un cancer de la prostate traité par prostatectomie radicale

21. P13. Spine SBRT: Benefit of Magnetic Resonance Imaging acquisition in treatment position and first results of Volumetric Modulated Arc Therapy dose plan.

22. SUN-LB280: Double Blind Multicenter Phase III Gortec Trial Evaluating the Efficacy of Oral Immune Modulating Formulae Therapy During Adjuvant Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC).

24. Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis.

25. [Challenges and limits of therapeutic de-escalation for papillomavirus-related oropharyngeal cancer].

26. Highly hypofractionated schedules for localized prostate cancer: Recommendations of the GETUG radiation oncology group.

27. Radiotherapy for oral cavity cancers.

28. Recommendations for planning and delivery of radical radiotherapy for localized urothelial carcinoma of the bladder.

29. Brachytherapy boost (BT-boost) or stereotactic body radiation therapy boost (SBRT-boost) for high-risk prostate cancer (HR-PCa).

30. Distinct Outcomes of Oropharyngeal Squamous Cell Carcinoma Patients after Distant Failure According to p16 Status: Implication in Therapeutic Options.

31. Laparoscopic closure of the pouch of Douglas by a peritoneal running suture. A minimally invasive and prosthetic-free technique to prevent excessive dose delivery to the small bowel during pelvic irradiation for prostate cancer.

32. Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial.

33. [Concurrent chemoradiotherapy for head neck cancers. Should organs at risk dose constraints be revisited ?]

34. [Indications and outlooks of radiohormonal therapy of high-risk prostate cancers].

35. Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial.

36. [Prostate brachytherapy: New techniques, new indications].

37. New approach of ultra-focal brachytherapy for low- and intermediate-risk prostate cancer with custom-linked I-125 seeds: A feasibility study of optimal dose coverage.

38. [Mediastinal lymph node and vertebral metastases 3 years after liver transplantation for cholangiocarcinoma: 2 unusual localizations].